GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » 3-Year Dividend Growth Rate

GlaxoSmithKline Pharmaceuticals (BOM:500660) 3-Year Dividend Growth Rate : 17.00% (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals 3-Year Dividend Growth Rate?

GlaxoSmithKline Pharmaceuticals's Dividends per Share for the three months ended in Mar. 2024 was ₹0.00.

The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's 3-Year Dividend Growth Rate or its related term are showing as below:

BOM:500660' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -17.6   Med: 12.1   Max: 45.8
Current: 17

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GlaxoSmithKline Pharmaceuticals was 45.80% per year. The lowest was -17.60% per year. And the median was 12.10% per year.

BOM:500660's 3-Year Dividend Growth Rate is ranked better than
61.34% of 313 companies
in the Drug Manufacturers industry
Industry Median: 11 vs BOM:500660: 17.00

During the past 12 months, GlaxoSmithKline Pharmaceuticals's average Dividends Per Share Growth Rate was 6.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 17.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, GlaxoSmithKline Pharmaceuticals's Dividend Yield % is 1.29%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of GlaxoSmithKline Pharmaceuticals Ltd is 0.78, which seems too high.

Warning Sign:

GlaxoSmithKline Pharmaceuticals Ltd stock dividend yield is close to 5-year low.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of GlaxoSmithKline Pharmaceuticals's 3-Year Dividend Growth Rate

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's 3-Year Dividend Growth Rate falls into.



GlaxoSmithKline Pharmaceuticals 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


GlaxoSmithKline Pharmaceuticals  (BOM:500660) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 11.06
=0.00

During the past 13 years, the highest Dividend Payout Ratio of GlaxoSmithKline Pharmaceuticals was 1.41. The lowest was 0.64. And the median was 0.78.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of GlaxoSmithKline Pharmaceuticals Ltd is 0.78, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

GlaxoSmithKline Pharmaceuticals Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
INR 32.0000002024-05-312024-05-312024-07-01Cash DividendannuallyINR:INR 1.000000
INR 32.0000002023-06-302023-06-302023-07-28Cash DividendannuallyINR:INR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

GlaxoSmithKline Pharmaceuticals's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=64/2505.10
=2.55 %

Current Share Price is ₹2505.10.
GlaxoSmithKline Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹64.

During the past 13 years, the highest Dividend Yield of GlaxoSmithKline Pharmaceuticals was 4.27%. The lowest was 0.86%. And the median was 1.70%.

Warning Sign:

GlaxoSmithKline Pharmaceuticals Ltd stock dividend yield is close to 5-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Pharmaceuticals 3-Year Dividend Growth Rate Related Terms>


GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines